SATSUMA PHARMACEUTICALS INC's ticker is STSA and the CUSIP is 80405P107.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $43,472 | -61.2% | 62,236 | -50.0% | 0.00% | – |
| Q4 2022 | $112,024 | -70.0% | 124,472 | +100.0% | 0.00% | – |
| Q3 2022 | $373,000 | +109.6% | 62,236 | +44.6% | 0.00% | – |
| Q2 2022 | $178,000 | +8.5% | 43,036 | 0.0% | 0.00% | – |
| Q1 2022 | $164,000 | +1.9% | 43,036 | +20.0% | 0.00% | – |
| Q4 2021 | $161,000 | +87.2% | 35,860 | +94.8% | 0.00% | – |
| Q3 2021 | $86,000 | -33.8% | 18,410 | 0.0% | 0.00% | – |
| Q2 2021 | $130,000 | -88.5% | 18,410 | -90.4% | 0.00% | – |
| Q1 2021 | $1,134,000 | +38.8% | 191,887 | +8.2% | 0.00% | – |
| Q4 2020 | $817,000 | +30.3% | 177,308 | +10.1% | 0.00% | – |
| Q3 2020 | $627,000 | -84.1% | 161,108 | +17.4% | 0.00% | – |
| Q2 2020 | $3,947,000 | +166.0% | 137,230 | +99.0% | 0.00% | – |
| Q1 2020 | $1,484,000 | +84.3% | 68,961 | +68.6% | 0.00% | – |
| Q4 2019 | $805,000 | – | 40,893 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 3,711,286 | $22,268,000 | 3.58% |
| NEA Management Company, LLC | 3,142,958 | $18,858,000 | 0.94% |
| Vivo Capital, LLC | 1,232,394 | $7,394,000 | 0.82% |
| RA Capital Management | 5,914,252 | $35,486,000 | 0.76% |
| Nan Fung Group Holdings Ltd | 177,900 | $1,067,000 | 0.68% |
| Ikarian Capital, LLC | 400,000 | $2,400,000 | 0.48% |
| SAMLYN CAPITAL, LLC | 2,929,195 | $17,575,000 | 0.33% |
| EAM Investors, LLC | 149,029 | $894,000 | 0.19% |
| TPG GP A, LLC | 1,885,939 | $11,316,000 | 0.18% |
| Ikarian Capital, LLC | 136,059 | $815,000 | 0.16% |